Tobacco Dependence Treatment: Scientific Challenges; Public Health Opportunities
Overview
Authors
Affiliations
The use of financial incentives in promoting smoking cessation.
Sigmon S, Patrick M Prev Med. 2012; 55 Suppl:S24-32.
PMID: 22525802 PMC: 3411852. DOI: 10.1016/j.ypmed.2012.04.007.
Regulatory strategies to reduce tobacco addiction in youth.
Henningfield J, Moolchan E, Zeller M Tob Control. 2003; 12 Suppl 1:i14-24.
PMID: 12773782 PMC: 1766091. DOI: 10.1136/tc.12.suppl_1.i14.
Subjective effects of the nicotine lozenge: assessment of abuse liability.
Houtsmuller E, Henningfield J, Stitzer M Psychopharmacology (Berl). 2003; 167(1):20-7.
PMID: 12616334 DOI: 10.1007/s00213-002-1361-2.
Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?.
Sims T, Fiore M CNS Drugs. 2002; 16(10):653-62.
PMID: 12269859 DOI: 10.2165/00023210-200216100-00001.
Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress?.
Henningfield J, Fagerstrom K Tob Control. 2001; 10(3):253-7.
PMID: 11544390 PMC: 1747582. DOI: 10.1136/tc.10.3.253.